Stock SLNO SOLENO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Soleno Therapeutics, Inc.

Equities

SLNO

US8342033094

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
42.08 USD -1.29% Intraday chart for Soleno Therapeutics, Inc. +2.24% +4.55%
May. 22 Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024 CI
May. 13 Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating MT

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Soleno Therapeutics, Inc. - Special Call
Transcript : Soleno Therapeutics, Inc. - Shareholder/Analyst Call
Transcript : Soleno Therapeutics, Inc. - Shareholder/Analyst Call
Transcript : Soleno Therapeutics, Inc. - Shareholder/Analyst Call
Transcript : Soleno Therapeutics, Inc. - Special Call
Transcript : Soleno Therapeutics, Inc. - Special Call
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SLNO Stock
  4. News Soleno Therapeutics, Inc.
  5. Transcripts